Many controversies surround screening for developmental dysplasia of the hip (DDH). The Ortolani 1 and Barlow tests 2 are accepted as the cornerstone of DDH clinical screening, 3,4 even if there is no adequate evidence of their accuracy. The positive predictive value (PPV) of clinical hip examination could be as low as 5%, 5 and referral rates are increasing. 6,7 Previous studies have not described the differences between the Ortolani and Barlow tests in terms of their PPV. However, it is widely accepted that the Ortolani test is the most important test as it indicates when the femoral head is dislocated at rest. 3,8,9 The spontaneous resolution of clinical instability makes the diagnosis of pathological hip dysplasia difficult. Delaying the hip
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.